United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 10, 2026 · Filed Jun 11, 2026

On Jun 10, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$545.83 for US$5.19M under a trading plan, leaving 40,513 shares. Filed Jun 11, 2026 (Form 4).

Sold
9,500 shares
Price
US$545.83 average (US$539.12 to US$557.04)
Value
US$5.19M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 10, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 10, 2026Common StockSale600US$539.1249,413Direct
Jun 10, 2026Common StockSale800US$540.1448,613Direct
Jun 10, 2026Common StockSale852US$541.1647,761Direct
Jun 10, 2026Common StockSale1,158US$542.2346,603Direct
Jun 10, 2026Common StockSale824US$543.2645,779Direct
Jun 10, 2026Common StockSale867US$544.3344,912Direct
Jun 10, 2026Common StockSale914US$545.1043,998Direct
Jun 10, 2026Common StockSale215US$546.1443,783Direct
Jun 10, 2026Common StockSale385US$547.0943,398Direct
Jun 10, 2026Common StockSale246US$548.6343,152Direct
Jun 10, 2026Common StockSale508US$549.7042,644Direct
Jun 10, 2026Common StockSale156US$550.5942,488Direct
Jun 10, 2026Common StockSale90US$551.6042,398Direct
Jun 10, 2026Common StockSale587US$553.6441,811Direct
Jun 10, 2026Common StockSale933US$554.5640,878Direct
Jun 10, 2026Common StockSale285US$555.2940,593Direct
Jun 10, 2026Common StockSale80US$557.0440,513Direct

Source

View original at SEC

Related